Cite
HARVARD Citation
Liu, D. et al. (2022). Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment. Cancer medicine. pp. 1796-1804. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liu, D. et al. (2022). Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment. Cancer medicine. pp. 1796-1804. [Online].